# Levocarnitine in Treating Fatigue in Cancer Patients

> **NCT00091169** · PHASE3 · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 376 (actual)

## Conditions studied

- Fatigue
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DIETARY_SUPPLEMENT:** levocarnitine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00091169
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12-16
- **Primary completion:** 2008-03
- **Final completion:** 2011-05
- **Target enrollment:** 376 (ACTUAL)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00091169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00091169, "Levocarnitine in Treating Fatigue in Cancer Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00091169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*